Skip to Content Facebook Feature Image

Cartier Thailand Partners with Chula to Celebrate Social Entrepreneurs and Graduates of the Cartier Women's Initiative Entrepreneurial Program

Business

Cartier Thailand Partners with Chula to Celebrate Social Entrepreneurs and Graduates of the Cartier Women's Initiative Entrepreneurial Program
Business

Business

Cartier Thailand Partners with Chula to Celebrate Social Entrepreneurs and Graduates of the Cartier Women's Initiative Entrepreneurial Program

2025-05-28 10:00 Last Updated At:10:15

BANGKOK, May 28, 2025 /PRNewswire/ -- Cartier Thailand, in collaboration with Chulalongkorn University, hosted a celebration honoring the achievements of social entrepreneurs who completed the Cartier Women's Initiative (CWI) Entrepreneurial Program—a short-term course for female entrepreneurs in Thailand. The event was presided over by Professor Dr. Wilert Puriwat, President of Chulalongkorn University, who presented certificates to the program's graduates. The opening speech was delivered by Ms. Pornpreya Vivadhnajat, Managing Director of Cartier Thailand, while Ms. Yanina Novitskaya, Chief Executive Officer of Cartier Southeast Asia and Oceania, extended her congratulations. The event was held on May 8, 2025, at the Waldorf Astoria Bangkok. 

The Cartier Women's Initiative (CWI)  is a global program reflecting Cartier's long-standing commitment to empowering female entrepreneurs who are driving social change through business solutions. In Thailand, this has been further developed into the CWI Entrepreneurial Program, aimed at equipping social entrepreneurs with essential skills and knowledge. The program covers fundamental business practices, leadership skills, business tools, and techniques that enable participants to scale their ventures internationally and potentially join the Cartier Women's Initiative Awards in the future. The ultimate goal is to help Thai entrepreneurs create a positive global impact through purpose-driven businesses. 

Professor Dr. Wilert Puriwat, President of Chulalongkorn University, remarked that the 26 graduates of the program are not only entrepreneurs but also changemakers. Over the six-week period, they stepped away from their business leadership roles to immerse themselves in this intensive course. The knowledge and experience they gained will prepare them to lead their ventures and discover innovative solutions to drive global change. This collaboration between Chulalongkorn University and Cartier reinforces a shared vision to support enterprises that go beyond profit and strive for social impact. He also invited interested parties to apply for the Cartier Women's Initiative Awards 2026, which will take place in 2026. 

Ms. Pornpreya Vivadhnajat, Managing Director of Cartier Thailand, stated that the CWI Entrepreneurial Program was designed to empower and build the capabilities of entrepreneurs committed to running sustainable businesses with meaningful purposes. She expressed admiration and inspiration from witnessing the growth of the program participants, who demonstrated creativity, collaboration, and the collective positive energy fostered within the community. 

Ms. Yanina Novitskaya, CEO of Cartier Southeast Asia and Oceania, shared her appreciation for the dedication and determination shown by all participants in the CWI Entrepreneurial Program. She noted that Thailand is among the leading countries in terms of female leadership, with many women in executive roles—highlighting the strong potential of Thai women. As the Cartier Women's Initiative approaches its 20th year, Thailand will host the awards ceremony in 2026. She encouraged program participants and other female social entrepreneurs to apply for this global initiative, which supports business and entrepreneurial growth within a vibrant community of social impact leaders. 

The Cartier Women's Initiative (CWI) Entrepreneurial Program is a six-week intensive course co-developed and managed by Cartier and Chulalongkorn University. It includes comprehensive content and practical exercises that span entrepreneurship fundamentals, business operations, and pitching techniques. The program is led by Dr. Preechaya Sittipunt, Chief Global Learning Officer. 

Female entrepreneurs running social enterprises are invited to apply for the Cartier Women's Initiative Awards 2026, even if they have not participated in the CWI Entrepreneurial Program. 

Applications are open now through June 24, 2025. Application forms and further information are available at: https://www.cartierwomensinitiative.com/awards 

View the photo album of this article at https://www.chula.ac.th/en/news/238707/ 

About Chulalongkorn University

"Chulalongkorn University proudly retains its No. 1 position among Thai universities and ranks 132nd in Asia out of more than 2,000 institutions in the THE Asia University Rankings 2025—a testament to the excellence of Thai higher education on the regional stage."

Social Media: 
Facebook: https://www.facebook.com/ChulalongkornUniversity
Youtube: https://www.youtube.com/chulauniversity
Linkedin: https://www.linkedin.com/school/15101896/

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Cartier Thailand Partners with Chula to Celebrate Social Entrepreneurs and Graduates of the Cartier Women's Initiative Entrepreneurial Program

Cartier Thailand Partners with Chula to Celebrate Social Entrepreneurs and Graduates of the Cartier Women's Initiative Entrepreneurial Program

T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors

Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer

Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.

"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."

Leadership and Board Expansion
Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.

 

 

To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.

Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.

"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."

About Alamar Biosciences, Inc. 
Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com

 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Recommended Articles